Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $16.5000 (3.77%) ($16.0000 - $17.0000) on Sat. Dec. 16, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.1% (three month average) | RSI | 34 | Latest Price | $16.5000(3.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.4% a day on average for past five trading days. | Weekly Trend | CAPR declines -7.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -6.05% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.05% (StdDev 12.1%) | Hourly BBV | 0 () | Intraday Trend | 3.1% | | | |
|
1 - 5 Day Possible Target | $-1.38(-108.36%) | Resistance Level | $18.71 | 5 Day Moving Average | $16.44(0.36%) | 10 Day Moving Average | $17.19(-4.01%) | 20 Day Moving Average | $18.71(-11.81%) | To recent high | -52.2% | To recent low | 25% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |